DGX vs. GEHC: Quest Diagnostics vs. GE HealthCare Stock Comparison

Company Profile

Quest Diagnostics (DGX) and GE HealthCare (GEHC) both fall under the Health Care Equipment & Services industry group, but DGX is classified in Health Care Providers & Services while GEHC is classified in Health Care Equipment & Supplies.

Quest Diagnostics (DGX) has more than two decades of public-market history since December 17, 1996, whereas GE HealthCare (GEHC) listed on December 15, 2022 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Quest Diagnostics (DGX) at 15.32% and GE HealthCare (GEHC) at 20.01% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

For every dollar of sales, both Quest Diagnostics (DGX) at 9.54% and GE HealthCare (GEHC) at 9.95% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Quest Diagnostics (DGX) at 15.63% and GE HealthCare (GEHC) at 15.33% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both Quest Diagnostics (DGX) at 11.78% and GE HealthCare (GEHC) at 4.84% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both Quest Diagnostics (DGX) at 13.78% and GE HealthCare (GEHC) at 4.84% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Quest Diagnostics (DGX) at 1.70 keeps current ratio within its industry’s typical mid-range, while GE HealthCare (GEHC) at 1.30 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for GEHC.

Both Quest Diagnostics (DGX) at 0.80 and GE HealthCare (GEHC) at 0.88 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Both Quest Diagnostics (DGX) at 1.33% and GE HealthCare (GEHC) at 0.17% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both Quest Diagnostics (DGX) at 25.10% and GE HealthCare (GEHC) at 2.96% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

Dividend Metrics

Valuation

GE HealthCare (GEHC) at 17.42 sits in the cheaper P/E ratio quartile, while Quest Diagnostics (DGX) at 25.46 is closer to its industry’s usual earnings multiple — a discount for GEHC, though growth and earnings durability still matter.

On P/S ratio, both Quest Diagnostics (DGX) at 2.38 and GE HealthCare (GEHC) at 1.72 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

On P/B ratio, both Quest Diagnostics (DGX) at 3.68 and GE HealthCare (GEHC) at 3.21 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics